Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Gao

Showing results (11-20 of 322) with videos related to

Pageof 33
Sort By:
Drug Discoveries & Therapeutics|August 1, 2017
Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carcinoma in China: ExpectationJianjun Gao, Peipei Song
Drug Discoveries & Therapeutics|November 11, 2014
Drug development for controlling Ebola epidemic - a race against timeJianjun Gao, Lin Yin
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2004
In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerismJianjun Gao, Khosrow Kashfi, Basil Rigas
Drug Discoveries & Therapeutics|April 13, 2025
Gepotidacin: The first-in-class triazaacenaphthylene antibiotic approved for the treatment of uncomplicated urinary tract infectionsShasha Hu, Haizhou Yu, Jianjun Gao
Bioscience Trends|February 16, 2016
Nosocomial infection and its molecular mechanisms of antibiotic resistanceJufeng Xia, Jianjun Gao, Wei Tang
The Lancet. Oncology|December 16, 2014
Towards effective adjuvant treatment for urothelial cancerArlene O Siefker-Radtke, Jianjun Gao
Bioscience Trends|February 20, 2020
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studiesJianjun Gao, Zhenxue Tian, Xu Yang
Drug Discoveries & Therapeutics|November 19, 2025
Elamipretide: The first cardiolipin-directed mitochondrial therapeutic for Barth syndrome approved under accelerated approvalChenru Zhao, Xuemei Zhuang, Jianjun Gao
Drug Discoveries & Therapeutics|October 29, 2025
Paltusotine: The first selective nonpeptide agonist of somatostatin receptor 2 (SSTR2) for the treatment of acromegalyYueyi Sun, Daoran Lu, Jianjun Gao
Drug Discoveries & Therapeutics|February 26, 2025
Suzetrigine: The first Nav1.8 inhibitor approved for the treatment of moderate to severe acute painShasha Hu, Dong Lyu, Jianjun Gao
Pageof 33

Showing results (11-20 of 322) with videos related to

Sort By:
Pageof 33
Drug Discoveries & Therapeutics|August 1, 2017
Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carcinoma in China: ExpectationJianjun Gao, Peipei Song
Drug Discoveries & Therapeutics|November 11, 2014
Drug development for controlling Ebola epidemic - a race against timeJianjun Gao, Lin Yin
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2004
In vitro metabolism of nitric oxide-donating aspirin: the effect of positional isomerismJianjun Gao, Khosrow Kashfi, Basil Rigas
Drug Discoveries & Therapeutics|April 13, 2025
Gepotidacin: The first-in-class triazaacenaphthylene antibiotic approved for the treatment of uncomplicated urinary tract infectionsShasha Hu, Haizhou Yu, Jianjun Gao
Bioscience Trends|February 16, 2016
Nosocomial infection and its molecular mechanisms of antibiotic resistanceJufeng Xia, Jianjun Gao, Wei Tang
The Lancet. Oncology|December 16, 2014
Towards effective adjuvant treatment for urothelial cancerArlene O Siefker-Radtke, Jianjun Gao
Bioscience Trends|February 20, 2020
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studiesJianjun Gao, Zhenxue Tian, Xu Yang
Drug Discoveries & Therapeutics|November 19, 2025
Elamipretide: The first cardiolipin-directed mitochondrial therapeutic for Barth syndrome approved under accelerated approvalChenru Zhao, Xuemei Zhuang, Jianjun Gao
Drug Discoveries & Therapeutics|October 29, 2025
Paltusotine: The first selective nonpeptide agonist of somatostatin receptor 2 (SSTR2) for the treatment of acromegalyYueyi Sun, Daoran Lu, Jianjun Gao
Drug Discoveries & Therapeutics|February 26, 2025
Suzetrigine: The first Nav1.8 inhibitor approved for the treatment of moderate to severe acute painShasha Hu, Dong Lyu, Jianjun Gao
Pageof 33